Saliva represents one of the most important protective factors in the oral cavity, yet its critical role is often overlooked. This clear, slightly alkaline fluid secreted by major and minor salivary glands performs multiple essential functions: mechanical cleansing, buffering acids, remineralizing early enamel lesions, antimicrobial defense, lubrication, and protein digestion. Adequate salivary function correlates directly with caries prevention, periodontal health, and oral comfort. Conversely, xerostomia (dry mouth due to reduced salivary flow) dramatically increases caries risk, oral infection susceptibility, and patient discomfort.
Salivary Composition and Source Glands
Saliva is produced by major salivary glands (parotid, submandibular, and sublingual glands) and hundreds of minor salivary glands distributed throughout the oral cavity. Parotid glands (in front of ears) produce 25% of saliva with serous secretion rich in enzymes. Submandibular glands (under jaw) produce 70% of saliva with mixed serous-mucous secretion containing more mucopolysaccharides. Minor glands produce 5% of saliva, with mucous predominance producing thick, viscous secretions.
Saliva is 99% water; remaining 1% contains inorganic ions (sodium, potassium, calcium, phosphate, chloride, bicarbonate) and organic components (proteins, lipids, carbohydrates). Calcium (1-2 mM concentration) and phosphate ions (1-3 mM) support remineralization. Bicarbonate (15-20 mM) and phosphate buffer systems prevent pH collapse. Mucins (glycoproteins) provide viscosity and lubrication. Enzymes include amylase (starch digestion), lipase (fat digestion), proteases (protein digestion), and antimicrobial enzymes (lysozyme, peroxidase, lactoferrin).
Salivary flow rates vary considerably: unstimulated resting flow is typically 0.25-0.35 mL/minute; stimulated flow (chewing, sucking) increases to 1-2 mL/minute. Total daily salivary production averages 0.5-1.5 liters. Salivary composition changes with flow rate; stimulated saliva has higher bicarbonate and calcium, enhancing buffering and remineralization capacity. Resting saliva is more viscous and provides prolonged lubrication between meals.
Buffering Capacity and Acid Neutralization
The buffering system in saliva is critical for preventing acid demineralization of enamel and dentin. When dietary carbohydrates are metabolized by oral bacteria, acids (primarily lactic acid) are produced within minutes, dropping plaque pH from 7.0 (neutral) to 4.5-5.0 (acidic). This demineralizing pH continues for 20-30 minutes after acid production ceases. Enamel demineralization begins at pH 5.5; dentin demineralization at pH 6.5.
Bicarbonate and phosphate buffer systems in saliva neutralize these acids, raising pH back toward neutral within 20-30 minutes if adequate salivary flow exists. Bicarbonate concentration increases substantially with stimulation (resting 2-3 mM; stimulated 15-20 mM), dramatically enhancing buffering capacity. Phosphate buffer system (hydrogen phosphate/dihydrogen phosphate equilibrium) provides additional capacity, particularly at resting pH.
Buffering capacity testing (titration to pH 6.0 with acid) provides clinical assessment of salivary caries-protective capacity. High buffering capacity (>5 mL of acid to reach pH 6.0) indicates excellent protective capacity; low buffering capacity (<3 mL) indicates increased caries risk. Reduced saliva flow dramatically impairs buffering; even if salivary components are normal, reduced flow rate means less buffering agent reaches carious sites.
Antimicrobial Proteins and Immune Defenses
Saliva contains multiple antimicrobial proteins providing first-line immune defense: (1) lysozyme (60-80 mg/L concentration)—degrades bacterial cell wall peptidoglycan, particularly effective against gram-positive bacteria; (2) lactoferrin (100-200 mg/L)—chelates iron required for bacterial growth, particularly inhibiting Streptococcus mutans; (3) histatins (0.5-1 mg/L)—peptides with antifungal and antibacterial properties, particularly important in candidiasis prevention; (4) peroxidase enzymes (lactoperoxidase)—generate reactive oxygen species inhibiting bacterial metabolism.
Secretory IgA (sIgA) represents the predominant immunoglobulin in saliva (150-200 mg/L), providing adaptive immune defense through antibody binding to bacterial antigens and preventing adherence to tooth surfaces and epithelium. Patients with IgA deficiency experience increased oral infections. IgM and IgG are also present in lower concentrations, particularly following infections or immune stimulation.
Mucins provide both protective and antimicrobial functions. MUC5B (major salivary mucin) forms protective coating on tooth surfaces and epithelium; MUC7 provides smaller glycoproteins with antimicrobial properties. Mucins bind bacteria, inhibiting adherence and promoting clearance through swallowing.
Antimicrobial efficacy of these components is demonstrated clinically: caries incidence is 2-3 fold higher in patients with reduced salivary flow despite maintained salivary composition, indicating flow-dependent protective capacity. Combination of salivary components provides superior antimicrobial effect compared to any single component alone.
Remineralization and Early Caries Arrest
Saliva supports remineralization of early enamel caries lesions—the ability to reverse noncavitated lesions through calcium and phosphate deposition back into demineralized crystal lattice. Lesion arrestment occurs through: (1) buffering pH to neutral, halting demineralization; (2) providing calcium and phosphate ions for crystal repair; (3) allowing fluoride (from toothpaste or professional application) to integrate into crystal structure, forming fluoroapatite more resistant to future acid attack.
Early caries lesions (white spot lesions, incipient carious changes on radiographs) are potentially reversible if arrested within 3-4 months. Studies demonstrate that aggressive remineralization protocols (fluoride varnish monthly, CPP-ACP calcium-phosphate application twice daily, dietary carbohydrate reduction) arrest 40-60% of early lesions within 3-4 months. Without intervention, similar lesions cavitate and require restoration within 6-12 months.
Calcium and phosphate supersaturation in saliva around tooth surfaces creates thermodynamic driving force for mineral deposition. This natural physiologic process becomes insufficient in patients with low salivary flow; supplemental calcium and phosphate (CPP-ACP formulations, calcium hydroxide pastes) enhance remineralization capacity. pH elevation (buffering acidic plaque) is essential; remineralization cannot occur in acidic environment below pH 5.5 for enamel.
Xerostomia: Etiology, Consequences, and Impact on Oral Health
Xerostomia (subjective perception of dry mouth) and salivary hyposalivation (objective reduced salivary flow <0.5 mL/min resting or <1 mL/min stimulated) occur in 10-40% of older adults and 5-10% of younger populations. Causes include: (1) medications (antihistamines, antidepressants, antihypertensives, anticholinergics—>400 medications cause xerostomia); (2) systemic diseases (Sjögren syndrome, diabetes, head/neck cancer, salivary gland dysfunction); (3) radiation therapy (salivary gland damage); (4) chemotherapy (salivary suppression, though usually reversible); (5) autoimmune conditions; (6) dehydration.
Xerostomia consequences include dramatically increased caries risk (10-50 fold increase depending on severity), severe periodontal disease (salivary antimicrobials and lubrication loss), opportunistic infections (oral candidiasis, bacterial infections), oral burning sensation, difficulty swallowing, altered taste, and compromised denture retention. Severe xerostomia creates devastating functional and quality-of-life impacts.
Caries patterns in xerostomic patients differ from typical caries: cervical and root surface caries predominate (rather than occlusal/interproximal); multiple surfaces become carious simultaneously; progression is often rapid (months to years compared to years for typical caries); restorations frequently fail due to continued decay at margins. Many xerostomic patients require extensive preventive protocols and frequent professional intervention.
Management of Xerostomia and Salivary Stimulation
Management strategies include: (1) salivary stimulation—sugar-free gum or lozenges stimulate residual salivary capacity; xylitol-containing products provide added antimicrobial benefit; pilocarpine (muscarinic agonist) increases salivary flow in 50-60% of patients but causes systemic side effects; cevimeline provides similar benefit with better tolerability; (2) salivary substitutes—saliva substitutes (carboxymethylcellulose, hydroxymethylcellulose) provide temporary lubrication and protective coating, typically requiring frequent application (6-8 times daily); (3) medication adjustment—consultation with prescribing physicians regarding alternative medications with less xerostomic potential; (4) hydration enhancement—frequent water sipping, humidifiers, oral sprays.
Aggressive caries prevention is essential in xerostomic patients: high-dose fluoride (5,000 ppm prescription toothpaste twice daily minimum, or 1.23% fluoride gel in custom trays 5 minutes daily), antimicrobial rinses (chlorhexidine 0.12% twice daily or essential oil rinses), frequent professional prophylaxis (3-4 month intervals or more), dietary modification (elimination of fermentable carbohydrates, frequent meals avoided), and remineralization agents (CPP-ACP applications).
Clinical Assessment of Salivary Function
Salivary function assessment includes: (1) patient history—subjective dry mouth, difficulty swallowing, nocturnal awakening to drink, medications, systemic conditions; (2) clinical examination—tongue appearance (glazed, fissured, atrophic mucosa vs normal), saliva pooling, mucosal texture (sticky, fragile); (3) quantitative salivary flow testing—unstimulated whole saliva collected for 5 minutes (normal >0.1 mL/min, hyposalivation <0.1 mL/min); stimulated saliva collected during paraffin chewing or sorbitol application (normal >1 mL/min, hyposalivation <0.7 mL/min); (4) qualitative assessment—salivary buffering capacity testing, viscosity evaluation, salivary protein assessment.
Caries risk assessment accounts for salivary flow and buffering capacity: patients with reduced flow/buffering are considered high-risk regardless of dietary habits or hygiene, necessitating intensive preventive protocols. Regular monitoring of salivary function in medicated patients or those with systemic disease allows early intervention if hyposalivation develops.
Prevention and Optimization of Salivary Health
Salivary health maintenance includes: (1) adequate hydration—minimum 2-3 liters daily water intake; (2) salivary stimulation—frequent gum chewing or lozenge use stimulates residual capacity; (3) medication review—optimizing medication regimens with physicians regarding xerostomic potential; (4) preventive dentistry—excellent oral hygiene, fluoride use, professional care supporting natural antimicrobial and remineralization capacity; (5) systemic health—managing diabetes, autoimmune conditions, and other salivary-affecting diseases.
Understanding saliva's critical protective role helps patients appreciate importance of salivary preservation and optimizing salivary health. For patients with medication-induced xerostomia or systemic disease, lifestyle modifications and professional intervention can substantially reduce caries and infection risk despite reduced salivary flow. Regular monitoring and tailored preventive protocols maintain oral health in xerostomic patients, though increased vigilance and more frequent professional intervention are required compared to those with normal salivary function.